|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,233.90 INR | +1.99% |
|
+1.91% | +9.76% |
| 31/07 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| 31/07 | Glenmark Pharmaceuticals Limited Announces Management Changes, Effective August 1, 2026 | CI |
| Market Cap | 63TCr 660.39Cr 574.07Cr 534.34Cr 490.59Cr 926.44Cr 940.79Cr 6.3TCr 2.47TCr 31TCr 2.48TCr 2.43TCr 1,05200Cr | P/E 2026 |
44.2x | P/E 2027 * | 26.8x |
|---|---|---|---|---|---|
| Enterprise Value | 59TCr 619.22Cr 538.29Cr 501.03Cr 460.01Cr 868.69Cr 882.15Cr 5.91TCr 2.32TCr 29TCr 2.33TCr 2.27TCr 99TCr | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.56x |
| Free-Float |
51.04% | Yield 2026 |
0.12% | Yield 2027 * | 0.24% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +1.99% | ||
| 1 week | +1.91% | ||
| 1 month | +1.34% | ||
| 3 months | -7.16% | ||
| 6 months | +10.81% | ||
| Current year | +9.76% |
| 1 week | 2,178.2 |  | 2,270.2 |
| 1 month | 2,142.8 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.99% | +1.91% | +4.68% | +183.54% | 660.39Cr | |
| -0.53% | +2.54% | +16.63% | +74.09% | 5TCr | |
| -1.81% | -0.49% | +51.99% | +112.44% | 3.66TCr | |
| +0.46% | +4.44% | -5.24% | +25.38% | 1.25TCr | |
| +1.05% | +1.63% | +16.19% | +78.22% | 1.18TCr | |
| -1.33% | -0.76% | +30.08% | +131.70% | 903.81Cr | |
| -2.99% | -2.09% | +41.02% | -8.36% | 702.99Cr | |
| +0.51% | +1.46% | +12.17% | +32.88% | 679.37Cr | |
| -.--% | +0.14% | - | - | 678.76Cr | |
| -.--% | -1.95% | - | - | 572.55Cr | |
| Average | -0.26% | +0.70% | +20.94% | +78.74% | 1.53TCr | |
| Weighted average by Cap. | -0.60% | +1.15% | +25.18% | +82.84% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 160.39Cr 139.43Cr 129.78Cr 119.15Cr 225.01Cr 228.5Cr 1.53TCr 600.38Cr 7.62TCr 602.37Cr 589.14Cr 26TCr | 17TCr 174.65Cr 151.82Cr 141.31Cr 129.74Cr 245.01Cr 248.8Cr 1.67TCr 653.74Cr 8.3TCr 655.9Cr 641.49Cr 28TCr |
| Net income | 2.05TCr 22Cr 19Cr 17Cr 16Cr 30Cr 31Cr 205.13Cr 81Cr 1.02TCr 81Cr 79Cr 3.43TCr | 2.33TCr 24Cr 21Cr 20Cr 18Cr 34Cr 35Cr 232.62Cr 91Cr 1.16TCr 92Cr 90Cr 3.89TCr |
| Net Debt | -3.93TCr -41Cr -36Cr -33Cr -31Cr -58Cr -59Cr -392.59Cr -154.08Cr -1.96TCr -154.59Cr -151.19Cr -6.56TCr | -3.71TCr -39Cr -34Cr -31Cr -29Cr -55Cr -55Cr -370.89Cr -145.56Cr -1.85TCr -146.04Cr -142.84Cr -6.2TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | ₹2,233.90 | +1.99% | 3,71,153 |
| 30/26/30 | ₹2,190.30 | -3.16% | 4,51,791 |
| 29/26/29 | ₹2,261.70 | +3.53% | 5,93,720 |
| 28/26/28 | ₹2,184.60 | -0.52% | 4,90,034 |
| 27/26/27 | ₹2,196.00 | +0.18% | 5,93,586 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
